June 11, 2010 – A new drug-eluting stent (DES) was launched this week in the European Union and other CE mark countries. The Taxus Element Paclitaxel-Eluting Coronary Stent System is Boston Scientific’s third-generation DES technology and incorporates a platinum chromium alloy with a new stent design and catheter delivery system.
